title: [Can ofloxacin constitute an alternative antitubercular treatment for BCG hepatitis?].
abstract: The authors report a case of severe BCG hepatitis resistant to tuberculostatic therapy and treated with ofloxacin. Modern antibiotics, such as certain fluoroquinolones, can constitute an alternative to tuberculostatic therapy in the management of serious adverse effects of BCG therapy.
authors.affiliation: Département d'Urologie, Hôpital Saint Joseph-Saint Luc, Lyon, France. jphilippe.fendler@wanadoo.fr
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Fendler
authors.forename: Henri
authors.initials: H
authors.lastname: Debois
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Mége
authors.forename: Georges
authors.initials: G
authors.lastname: Kepenekian
mesh_terms: D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D006505:Hepatitis / Q000188:drug therapy* / Q000382:microbiology*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009163:Mycobacterium bovis / Q000187:drug effects / Q000302:isolation & purification*; D015242:Ofloxacin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000890:Anti-Infective Agents; D000995:Antitubercular Agents; D015242:Ofloxacin